Reuters logo
BRIEF-ALK Abello: Acarizax data results in change to the gina asthma management strategy
February 27, 2017 / 2:22 PM / 7 months ago

BRIEF-ALK Abello: Acarizax data results in change to the gina asthma management strategy

Feb 27 (Reuters) - Alk-abello A/S:

* Acarizax data results in significant change to the GINA asthma management strategy: sublingual allergy immunotherapy (slit) recommended as a treatment option in patients with house dust mite allergic asthma Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below